The neurofibromatoses
- PMID: 20308235
- DOI: 10.1136/jnnp.2010.206532
The neurofibromatoses
Abstract
Neurofibromatosis 1 (NF1) and neurofibromatosis 2 (NF2) are inherited autosomal dominant disorders that have a significant impact on the nervous system and predispose to tumour formation. The current nomenclature makes NF1 and NF2 awkward bedfellows because they are clinically and genetically separate disorders. Neurofibromas are characteristic of NF1, a common condition with major skin involvement and many clinical complications. By contrast, schwannomas are the distinctive lesions in NF2, cutaneous signs are less prominent in this rarer disorder and clinical manifestations are largely restricted to the nervous system and eye. The current aim of neurofibromatosis specialists is to provide cohesive standards of care for everyone with neurofibromatosis and to devise standardised protocols for assessment and management within a multidisciplinary setting.
Similar articles
-
[Neurofibromatosis].Neurochirurgie. 1998 Nov;44(4):267-72. Neurochirurgie. 1998. PMID: 9864698 Review. French.
-
[Neurofibromatosis versus schwannomatosis].Fortschr Neurol Psychiatr. 1998 Jun;66(6):271-7. doi: 10.1055/s-2007-995262. Fortschr Neurol Psychiatr. 1998. PMID: 9676422 German.
-
Head and neck manifestations of neurofibromatosis.J La State Med Soc. 1994 May;146(5):183-6. J La State Med Soc. 1994. PMID: 8027629
-
The different forms of neurofibromatosis.Childs Nerv Syst. 1999 Jul;15(6-7):295-308. doi: 10.1007/s003810050398. Childs Nerv Syst. 1999. PMID: 10461778 Review.
-
Schwannomatosis: the overlooked neurofibromatosis?AJR Am J Roentgenol. 2013 Jun;200(6):W646-53. doi: 10.2214/AJR.12.8577. AJR Am J Roentgenol. 2013. PMID: 23701098 Review.
Cited by
-
Understanding the Biological Activities of Vitamin D in Type 1 Neurofibromatosis: New Insights into Disease Pathogenesis and Therapeutic Design.Cancers (Basel). 2020 Oct 13;12(10):2965. doi: 10.3390/cancers12102965. Cancers (Basel). 2020. PMID: 33066259 Free PMC article. Review.
-
Modeling cognitive dysfunction in neurofibromatosis-1.Trends Neurosci. 2013 Apr;36(4):237-47. doi: 10.1016/j.tins.2012.12.002. Epub 2013 Jan 8. Trends Neurosci. 2013. PMID: 23312374 Free PMC article. Review.
-
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.Neurooncol Pract. 2024 Jan 4;11(4):395-403. doi: 10.1093/nop/npae001. eCollection 2024 Aug. Neurooncol Pract. 2024. PMID: 39006526 Free PMC article.
-
Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.Hum Genomics. 2012 Sep 4;6(1):18. doi: 10.1186/1479-7364-6-18. Hum Genomics. 2012. PMID: 23244685 Free PMC article.
-
Neurofibromatosis: types 1 and 2.AJNR Am J Neuroradiol. 2013 Dec;34(12):2250-1. doi: 10.3174/ajnr.A3534. Epub 2013 Apr 18. AJNR Am J Neuroradiol. 2013. PMID: 23598837 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous